6 results match your criteria: "Shijiazhuang Obstetrics and Gynecology Hospital affiliated to Hebei Medical University[Affiliation]"
Compare Two Kinds of Recurrent MI-Arrest Oocytes.
J Obstet Gynaecol India
August 2023
The Center for Reproductive Medicine and Infertility, The Fourth Hospital of Shijiazhuang, Shijiazhuang Obstetrics and Gynecology Hospital affiliated to Hebei Medical University, Hebei Key Laboratory of Maternal and Fetal Medicine, Shijiazhuang, 050011 Hebei People's Republic of China.
Comparing the pregnancy outcomes of Re‑ICSI and ICSI embryos in fresh ET and FET cycles.
Biomed Rep
October 2023
The Center for Reproductive Medicine and Infertility, The Fourth Hospital of Shijiazhuang, Shijiazhuang Obstetrics and Gynecology Hospital Affiliated to Hebei Medical University, Key Laboratory of Maternal and Fetal Medicine of Hebei, Shijiazhuang, Hebei 050011, P.R. China.
Early rescue intracytoplasmic sperm injection (Re-ICSI) can prevent total fertilization failure (TFF) during conventional fertilization (IVF). However, the implantation rate of Re-ICSI embryos is lower than that of direct ICSI during fresh embryo transfer (ET). The aim of the present study was to investigate the effect of frozen ET (FET) after Re-ICSI.
View Article and Find Full Text PDFEstablishment and verification of hysteroscopic scoring system for chronic endometritis in infertile patients.
Zhejiang Da Xue Xue Bao Yi Xue Ban
February 2023
Reproductive Medicine Center, Shijiazhuang Obstetrics and Gynecology Hospital Affiliated to Hebei Medical University, Shijiazhuang 050035, China.
Objectives: To establish and verify a hysteroscopic scoring system for the diagnosis of chronic endometritis (CE) in infertile patients.
Methods: A total of 238 infertile patients who underwent hysteroscopy and endometrial biopsy in the Reproductive Medicine Center, Shijiazhuang Obstetrics and Gynecology Hospital Affiliated to Hebei Medical University from October 1 to December 31, 2019 were enrolled in the study. According to the results of CD138 immunohistochemistry, the patients were divided into CE group (=73) and non-CE group (=165).
Pregnancy outcome and follow-up of offspring of donor oocytes recipient from PCOS patients.
BMC Pregnancy Childbirth
October 2022
The Center for Reproductive Medicine and Infertility, The Fourth Hospital of Shijiazhuang, Shijiazhuang Obstetrics and Gynecology Hospital affiliated to Hebei Medical University, 206 Zhong-Shan-Dong, Shijiazhuang, Hebei, 050011, People's Republic of China.
Article Synopsis
- This study investigates the pregnancy outcomes of women with polycystic ovarian syndrome (PCOS) who receive donor oocytes compared to non-PCOS recipients.
- The research involves a retrospective analysis of 62 patients, divided into two groups (30 with PCOS and 32 without), to assess various reproductive health metrics such as fertilization rates and pregnancy complications.
- Findings indicate that there are no significant differences in key outcomes between the two groups, including rates of implantation, early abortion, and complications during pregnancy, suggesting that PCOS does not adversely affect outcomes in oocyte donation.
Impact of subchorionic hematoma on pregnancy outcomes in women with recurrent pregnancy loss.
Biomol Biomed
February 2023
Department of Gynecology, The First Hospital of Hebei Medical University, Shijiazhuang, China.
We conducted a retrospective cohort study with the aim of investigating the relationship between subchorionic hematoma (SCH) and pregnancy outcomes in women with recurrent pregnancy loss (RPL). We reviewed all RPL patients who came to the Fourth Hospital of Shijiazhuang from January 2019 to June 2021. Two groups were divided according to the presence or absence of SCH.
View Article and Find Full Text PDFFrozen blastocysts: Assessing the importance of day 5/day 6 blastocysts or blastocyst quality.
Exp Ther Med
May 2022
The Center for Reproductive Medicine and Infertility, The Fourth Hospital of Shijiazhuang, Shijiazhuang Obstetrics and Gynecology Hospital Affiliated to Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China.
The aim of the present study was to analyze the high-quality blastocyst (HB) rate in all embryo frozen cycles and investigate the pregnancy outcomes for day 5/day 6 (D5/D6) blastocysts with respect to the blastocyst quality in programmed single vitrified-warmed blastocyst transfer (SVBT). We performed a retrospective study comparing D5/D6 HBs in fertilization/intracytoplasmic sperm injection (IVF/ICSI) for all blastocyst frozen cycles. Patients were <35 years at the oocyte collection in their first fresh cycle without fresh transfer.
View Article and Find Full Text PDF